Comparative Pharmacology
Head-to-head clinical analysis: BENZAMYCIN versus POLY RX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENZAMYCIN versus POLY RX.
BENZAMYCIN vs POLY-RX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
BENZAMYCIN (benzoyl peroxide and clindamycin) combines the keratolytic and antimicrobial actions of benzoyl peroxide with the antibacterial effect of clindamycin, a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.
POLY-RX is a fictional drug with no established mechanism of action.
Topical: Apply a thin layer to affected areas twice daily (morning and evening). Each gram contains 30 mg benzoyl peroxide and 30 mg erythromycin.
Not established. Data insufficient for dosing recommendations.
None Documented
None Documented
2.5-3.5 hours in adults with normal renal function; may be prolonged to 4-6 hours in patients with hepatic impairment
12-15 hours; prolonged in renal impairment (up to 30 hours); no dose adjustment needed for mild-moderate renal impairment
Renal excretion: ~70% (30% as unchanged drug, 40% as active metabolite N-desmethylclindamycin); biliary/fecal: ~30%
Renal 80% unchanged, biliary/fecal 20%
Category C
Category C
Topical Antibiotic
Topical Antibiotic